ZA200704684B - Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease - Google Patents

Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease

Info

Publication number
ZA200704684B
ZA200704684B ZA200704684A ZA200704684A ZA200704684B ZA 200704684 B ZA200704684 B ZA 200704684B ZA 200704684 A ZA200704684 A ZA 200704684A ZA 200704684 A ZA200704684 A ZA 200704684A ZA 200704684 B ZA200704684 B ZA 200704684B
Authority
ZA
South Africa
Prior art keywords
treatment
inflammatory bowel
bowel disease
antisense oligonucleotide
oligonucleotide composition
Prior art date
Application number
ZA200704684A
Inventor
Mark K Wedel
Original Assignee
Isis Phamaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Phamaceuticals Inc filed Critical Isis Phamaceuticals Inc
Publication of ZA200704684B publication Critical patent/ZA200704684B/en

Links

ZA200704684A 2004-12-02 2007-06-04 Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease ZA200704684B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63282604P 2004-12-02 2004-12-02

Publications (1)

Publication Number Publication Date
ZA200704684B true ZA200704684B (en) 2008-09-25

Family

ID=39251208

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704684A ZA200704684B (en) 2004-12-02 2007-06-04 Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease

Country Status (2)

Country Link
CN (1) CN101151035A (en)
ZA (1) ZA200704684B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE032368T2 (en) * 2008-11-13 2017-09-28 Nogra Pharma Ltd Antisense compositions and methods of making and using same
WO2013173789A2 (en) 2012-05-17 2013-11-21 Isis Pharmaceuticals, Inc. Antisense oligonucleotide compositions
HUE051680T2 (en) * 2012-05-24 2021-03-29 Ionis Pharmaceuticals Inc Methods and compositions for modulating apolipoprotein(a) expression
CN103820438B (en) * 2014-02-13 2016-02-03 中国人民解放军军事医学科学院基础医学研究所 Improve the RNA molecule of mescenchymal stem cell osteogenic ability and action target spot thereof and application

Also Published As

Publication number Publication date
CN101151035A (en) 2008-03-26

Similar Documents

Publication Publication Date Title
EP1668024A4 (en) Oligonucleotide compositions and methods for treating disease including inflammatory conditions
IL178730A0 (en) New pharmaceutical compositions for the treatment of sexual disorders ii
IL152127A0 (en) Probiotic compositions for the treatment of inflammatory bowel disease
IL189611A0 (en) Treatment of inflammatory bowel disease
HK1107026A1 (en) Treatment of short bowel syndrome patients with colon-in-continuity
IL178827A0 (en) Use of reboxetine for the treatment of pain
EP1827459A4 (en) Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease
EP1954800A4 (en) Composition and use of phyto-percolate for treatment of disease
GB0320238D0 (en) Treatment of disease
EP1755635A4 (en) Treatment of inflammatory airway disease
EP1928247A4 (en) Composition and use of phyto-percolate for treatment of disease
EP1815867A4 (en) Combination drug for treating autoimmune disease
EP1768656A4 (en) Treatment for ocular disease
ZA200704684B (en) Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease
EP2044957A4 (en) Treatment agent for inflammatory bowel disease
GB0526394D0 (en) Treatment of inflammatory diseases
GB0400802D0 (en) Compounds for the treatment of disease
EP1806137A4 (en) Therapeutic agent for glomerular disease
IL186286A0 (en) Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions
EP1876175A4 (en) Therapeutic agent for corneal disease
TWI315984B (en) Agent for treatment of anal disease
GB0425854D0 (en) Therapeutic treatment
ZA200607463B (en) New pharmaceutical compositions for the treatment of sexual disorders II
GB0623740D0 (en) Treatment of disease
IL183926A0 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-kB ACTIVITY